PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin Launches Neumentix™ in Europe for Mind and Body Support European Product Launch and Presentation of Clinical Research At Vitafoods Europe - Kemin is pleased to announce the launch in Europe of Neumentix™ Phenolic Complex K110-42 - Kemin.com
Kemin Launches Neumentix™ in Europe for Mind and Body Support European Product Launch and Presentation of Clinical Research At Vitafoods Europe

 

NewswireToday - /newswire/ - Lisbon, Portugal, 2015/04/27 - Kemin is pleased to announce the launch in Europe of Neumentix™ Phenolic Complex K110-42 - Kemin.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Kemin is pleased to announce the launch in Europe of Neumentix™ Phenolic Complex K110-42, a proprietary phenolic complex sourced from patent-pending, non-GMO lines of Kemin Industries’ own purpose-grown spearmint for use in food supplements. Backed by two human clinical trials, Neumentix has been shown to provide natural support for an important component of cognitive performance - working memory - in addition to other unique related benefits.

Neumentix is derived from patent-pending, non-GMO lines of spearmint developed by Kemin plant scientists using traditional plant-breeding methods and grown in the USA on family farms that have been passed down from generation to generation. “There is a high demand for innovative cognitive health ingredients, and the solid clinical results open up great opportunities for customers who use Neumentix in their finished products”, said Pedro Vieira, vice president of sales & marketing for the human nutrition and health division of Kemin in Europe and South America.

Cognitive health and performance were assessed in the study “Effects of a Proprietary Spearmint Extract on Cognitive Function and Tolerance Parameters in Men and Women with Age-Associated Memory Impairment”. Several validated clinical questionnaires were used including the Cognitive Drug Research (CDR) battery of tests, the Profile of Mood States (POMS) and the Leeds Sleep Evaluation Questionnaire (LSEQ). In this 90 day randomized, double-blind, placebo-controlled study, adults who took Neumentix showed significantly better quality of working memory - a type of memory critical to a wide range of cognitive tasks including multi-tasking and complex thought - compared to those who took placebo. In addition, people taking Neumentix also reported that they got to sleep easier and faster at night. Working memory is highly affected by the aging process and other factors such as stress or lack of sleep. This data suggests Neumentix helps to improve cognitive performance in adults and confirms the findings observed in the pilot open-label human clinical trial and the in-vivo study conducted at the beginning of product development.

Kemin will present the latest scientific and clinical data on Neumentix on Wednesday, May 6 at 2 pm in the Vitafoods Europe Exhibitor Presentation Theatre. To learn more about Neumentix and the research behind one of the newest cognitive innovations, visit Kemin at stand L36 where you may challenge your working memory and measure your eye macular pigment!

About Kemin Inspired Molecular Solutions™
Kemin (kemin.com) provides “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where approximately 500 specialty ingredients are made for the global feed and food industries as well as the health, nutrition and beauty markets. A privately held, family-owned and operated company, Kemin has nearly 2,000 employees and operates in more than 90 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.

™® Trademarks of Kemin Industries, Inc.
Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin Launches Neumentix™ in Europe for Mind and Body Support European Product Launch and Presentation of Clinical Research At Vitafoods Europe

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Miguel Martinho - Kemin.com 
+351 214 157 500 miguel.martinho[.]kemin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0
MDxHealth Announces Agreement with Istituto Diagnostico Varelli for Distribution of SelectMDx Throughout Central-South Italy
BD Veritor™ System Meets FDA’s New Performance Requirements for Rapid Influenza Antigen Detection Tests
Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)